United Therapeutics Corporation (UTHR) 12th Annual Cantor Fitzgerald Global Healthcare Conference September 9, 2026 2:10 PM EDT
Company Participants
Martine Rothblatt – Founder, Chairman & CEO
James Edgemond – CFO & Treasurer
Conference Call Participants
Olivia Brayer – Cantor Fitzgerald & Co., Research Division
Presentation
Olivia Brayer
Cantor Fitzgerald & Co., Research Division
Hi. Good afternoon, everyone. Welcome to Day 1 of our Cancer Healthcare Conference. Hopefully, you guys can hear me okay. My name is Olivia Brayer. I’m one of the senior biotech analysts here at Cantor and really excited for this fireside chat. We have Martine Rothblatt, Founder and CEO of United Therapeutics. And of course, James Edgemond, who is CFO. Thank you both for joining us.
Martine Rothblatt
Founder, Chairman & CEO
Thank you, Olivia. And I’m also happy to mention that Harry Silvers, our Head of Investor Relations is right there in the front row and available a few questions afterwards.
Question-and-Answer Session
Olivia Brayer
Cantor Fitzgerald & Co., Research Division
Harry, we’ll make sure he keeps us all in check up here on stage. Well, it has been quite a year for United Therapeutics. Big year clinically. I think people are really excited about the momentum and what 2027 has to bring. So I mean maybe just set the stage for where the company is today and how you think about what could be a very big inflection and transformation for the company from here?
Martine Rothblatt
Founder, Chairman & CEO
Olivia, you are so right that we are in the absolute best position we have ever been in the company. It’s very rare in a company’s life that you get to see present when it kind of inflects from, say, like a kid to an adult type of company, that sort of thing. And that’s where we are with United Therapeutics. We
#United #Therapeutics #Corporation #UTHR #Presents #12th #Annual #Cantor #Fitzgerald #Global #Healthcare #Conference #Transcript
About the Author
